<?xml version="1.0" encoding="UTF-8"?>
<p>These developments make MR increasingly accessible, enabling ‘high-throughput’ projects such as an online platform collating over 5000 GWASs to facilitate MR for Parkinson’s disease (
 <xref rid="fcaa031-B67" ref-type="bibr">Noyce 
  <italic>et al.</italic>, 2019
 </xref>). Nonetheless, it remains crucial to perform MR studies with a reasoned approach, carefully tailored to the research question (
 <xref rid="fcaa031-B15" ref-type="bibr">Burgess and Davey Smith, 2019</xref>). Together with ethnically diverse data and GWASs for progression (
 <xref rid="fcaa031-B12" ref-type="bibr">Blauwendraat 
  <italic>et al.</italic>, 2019
 </xref>; 
 <xref rid="fcaa031-B48" ref-type="bibr">Iwaki 
  <italic>et al.</italic>, 2019
 </xref>), these resources will expedite MR for neurodegenerative disease prevention and drug development.
</p>
